Activation of AP-1 contributes to the β-adrenoceptor-mediated myocardial induction of interleukin-6

Molecular Medicine

Volumn 13, Issue 11-12, 2007, Pages 605-614

  Rohrbach, Susanne ^a   Engelhardt, Stefan ^b   Lohse, Martin J ^c   Werdan, Karl ^a   Holtz, Juergen ^a   Muller Werdan, Ursula ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b Deutsche Forschungsgemeinschaft   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING PROTEIN 1; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLIC AMP; ENDOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; ISOPRENALINE; PROTEIN; UNCLASSIFIED DRUG;

ADULT; ANALYTIC METHOD; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE; HEART MUSCLE CELL; HUMAN; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TRANSGENIC MOUSE;

ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CELLS, CULTURED; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEART FAILURE; INTERLEUKIN-6; MICE; MICE, TRANSGENIC; MYOCARDIUM; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, BETA; TRANSCRIPTION FACTOR AP-1;

EID: 36849090185     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/2007-00071.Rohrbach     Document Type: Article

References (32)

1. Knuefermann P, Vallejo J, Mann DL. (2004) The role of innate immune responses in the heart in health and disease. Trends Cardiovasc. Med. 14:1-7.
2. Mann DL. (2003) Stress-activated cytokines and the heart: from adaptation to maladaptation. Annu. Rev. Physiol. 65:81-101.
3. Sekiguchi K, Li X, Coker M, Flesch M, Barger PM, Sivasubramanian N, Mann DL. (2004) Cross-regulation between the renin-angiotensin system and inflammatory mediators in cardiac hypertrophy and failure. Cardiovasc. Res. 63:433-42.
4. Pruett SB. (2001) Quantitative aspects of stress-induced immunomodulation. Int. Immunopharmacol. 1:507-20.
5. Murray DR, Prabhu SD, Chandrasekar B. (2000) Chronic beta-adrenergic stimulation induces myocardial proinflammatory cytokine expression. Circulation 101:2338-41.
6. Yin F, Li P, Zheng M et al. (2003) Interleukin-6 Family of Cytokines Mediates Isoproterenol-induced Delayed STAT3 Activation in Mouse Heart. J. Biol. Chem. 278:21070-5.
7. Yin F, Wang YY, Du JH, Li C, Lu ZZ, Han C, Zhang YY. (2006) Noncanonical cAMP pathway and p38 MAPK mediate beta2-adrenergic receptor-induced IL-6 production in neonatal mouse cardiac fibroblasts. J. Mol. Cell. Cardiol. 40:384-93.
8. Briest W, Rassler B, Deten A, et al. (2003) Norepinephrine-induced interleukin-6 increase in rat hearts: differential signal transduction in myocytes and non-myocytes. Pflugers Arch. 446:437-46.
9. Deten A, Volz HC, Holzl A, Briest W, Zimmer HG. (2003) Effect of propranolol on cardiac cytokine expression after myocardial infarction in rats. Mol. Cell. Biochem. 251:127-37.
10. Prabhu SD, Chandrasekar B, Murray DR, Freeman GL. (2000) beta-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling. Circulation 101:2103-9.
11. Northemann W, Braciak TA, Hattori M, Lee F, Fey GH. (1989) Structure of the rat interleukin 6 gene and its expression in macrophage-derived cells. J. Biol. Chem. 264:16072-82.
12. Funakoshi Y, Ichiki T, Ito K, Takeshita A. (1999) Induction of interleukin-6 expression by angiotensin II in rat vascular smooth muscle cells. Hypertension 34:118-25.
13. Werdan K, Erdmann E. (1989) Preparation and culture of embryonic and neonatal heart muscle cells: modification of transport activity. Methods Enzymol. 173:634-62.
14. 1-adrenergic receptor transgenic mice. Proc. Natl. Acad. Sci. 96:7059-64.
15. 1-subtype in the rat heart. J. Mol. Cell. Cardiol. 33:561-73.
16. Müller FU, Bokník P, Knapp J, Linck B, Lüss H, Neumann J, Schmitz W. (2001) Activation and inactivation of cAMP-response element-mediated gene transcription in cardiac myocytes. Cardiovasc. Res. 52:95-102.
17. Shaulian E, Karin M. (2002) AP-1 as a regulator of cell live and death. Nat. Cell. Biol 4:E131-6.
18. Kondo A, Mogi M, Koshihara Y, Togari A. (2001) Signal transduction system for interleukin-6 and interleukin-11 synthesis stimulated by epinephrine in human osteoblasts and human osteogenic sarcoma cells. Biochem. Pharmacol. 61:319-26.
19. Akira S, Hirano T, Taga T, Kishimoto T. (1990) Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB J. 4:2860-7.
20. Purcell NH, Tang G, Yu C, Mercurio F, DiDonato JA, Lin A. (2001) Activation of NF-kB is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes. Proc. Natl. Acad. Sci. 98:6668-73.
21. Freund C, Schmidt-Ullrich R, Baurand A et al. (2005) Requirement of nuclear factor-kappaB in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivo. Circulation 111:2319-25.
22. Grabellus F, Levkau B, Sokoll A et al. (2002) Reversible activation of nuclear factor-κB in human end-stage heart failure after left ventricular mechanical support. Cardiovasc. Res. 53:124-30.
23. Frantz S, Kobzik L, Kim YD, Fukazawa R, Medzhitov R, Lee RT, Kelly RA. (1999) Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J. Clin. Invest. 104:271-80.
24. Zolk O, Ng LL, O'Brien RJ, Weyand M, Eschenhagen T. (2002) Augmented expression of cardiotrophin-1 in failing human hearts is accompanied by diminished glycoprotein 130 receptor protein abundance. Circulation 106:1442-6.
25. Podewski EK, Hilfiker-Kleiner D, Hilfiker A, Morawietz H, Lichtenberg A, Wollert KC, Drexler H. (2003) Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy. Circulation 107:798-802.
26. Kamimura D, Ishihara K, Hirano T. (2003) IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev. Physiol. Biochem. Pharmacol. 149:1-38.
27. Fischer P, Hilfiker-Kleiner D. (2007) Survival pathways in hypertrophy and heart failure: The gp130-STAT3 axis. Basic Res. Cardiol. 102:279-97.
28. Hunter JJ, Chien KR. (1999) Signaling pathways for cardiac hypertrophy and failure. N. Engl. J. Med. 341:1276-83.
29. Hirota H, Chen J, Betz U et al. (1999) Loss of gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell 97:189-98.
30. Müller-Werdan U, Schumann H, Loppnow H et al. (1998) Endotoxin and tumor necrosis factor α exert a similar proinflammatory effect in neonatal rat cardiomyocytes, but have different cardiodepressant profiles. J. Mol. Cell. Cardiol. 30:1027-36.
31. Gulick T, Chung MK, Pieper SJ, Lange LG, Schreiner GF. (1989) Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness. Proc. Natl. Acad. Sci. 86:6753-7.
32. Kubota T, McTiernan CF, Frye CS, et al. (1997) Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ. Res. 81:627-35.